TABLE 1.

Demographic Characteristics of Vaccinated Study Population

VariableData
Mean age ± SD (y)67 ± 12 (range, 20–95)
Female207 (49%)
PET/CT scan indication
 Solid tumor357 (83%)
 Hematologic malignancy66 (16%)
 Inflammation or infection4 (1%)
Treatment*
 No current treatment235 (55%)
 Targeted therapy†74 (17%)
 Chemotherapy71 (16%)
 Immunotherapy48 (11%)
 Steroids27 (6%)
 Other immunosuppressive treatment‡4 (1%)

  • *Some patients received more than 1 treatment.

  • ↵†Tyrosine kinase inhibitors, hormonal therapy, or proteasome inhibitors.

  • ↵‡Rituximab, daratumumab, or bone marrow transplantation.

  • Data are number followed by percentage in parentheses, except for age Total n = 426.